Rep. Brian J. Mast

Maddy summaryHCONRES 9 is a symbolic resolution passed by the U.S. House of Representatives that formally denounces socialism as incompatible with American values, citing historical examples of socialist regimes causing widespread suffering and authoritarian rule. It states Congress opposes the implementation of socialist policies in the United States. This resolution has no legal effect, does not change any laws, and serves solely as a non-binding statement of congressional opinion. It directly affects no individuals or policies, as it is purely a declarative position.

This resolution condemns Iranian state-sponsored terrorist attacks against U.S. citizens and officials and Iranian dissidents. The resolution also expresses support for the people of Iran who are legitimately defending their rights for freedom against repression and condemns the killing of Iranian protesters by the Iranian regime.

Protecting Dogs Subjected to Experiments Act This bill prohibits the National Institutes of Health from funding biological, medical, or behavioral research that involves testing dogs.

Prohibition of Agricultural Land for the People's Republic of China Act This bill requires the President to prohibit nonresident aliens, foreign businesses, and agents associated with China's government from (1) purchasing agricultural (including ranching) real estate located in the United States, or (2) participating in Department of Agriculture programs that are unrelated to food and safety regulatory requirements.

Ceasing Age-Based Trucking Restrictions Act This bill exempts drivers who transport goods from a port of entry and another place within the same state from age restrictions and other requirements that apply to federal commercial driver's licenses.

Maddy summaryThe Restoring Military Focus Act (HR 678) repeals the Chief Diversity Officer position in the Department of Defense and prohibits the creation of similar roles. It specifically eliminates two existing positions: the Chief Diversity Officer (under pre-2021 Title 10, U.S. Code) and the Senior Advisor for Diversity and Inclusion (under the 2021 National Defense Authorization Act). The bill bans federal funding for any new position that matches or closely resembles these roles. This directly affects the Department of Defense's organizational structure by removing diversity-focused leadership roles and preventing their replacement.

Maddy summaryThe HEAL Act (HR 603) requires the U.S. Holocaust Memorial Museum Director to study how public elementary and secondary schools teach about the Holocaust and related antisemitism. The study will examine curriculum requirements, teaching methods (like project-based learning), instructional materials, and assessment approaches across states and school districts. It specifically analyzes whether Holocaust education is mandatory, optional, or integrated across subjects, and how schools address antisemitism and genocide prevention. The resulting report, due within 180 days of the study or three years after enactment, will inform Congress but does not change current school policies. This is a data-gathering measure, not a policy mandate.

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.

Maddy summaryHCONRES 7 is a symbolic resolution passed by the U.S. House of Representatives that commends Iranian protesters - particularly women - who have risked safety to demonstrate against the Iranian regime's human rights abuses, including the mandatory hijab law and violent crackdowns following Mahsa Amini's death. It condemns the regime's use of violence (reportedly killing over 450 protesters) and detention of activists, while urging the Biden Administration to impose additional human rights sanctions on officials involved in repression and support internet freedom tools to bypass Iranian censorship. The resolution makes no binding policy changes but formally expresses congressional support for protesters' demands for freedom, justice, and an end to discriminatory laws targeting women. It does not directly affect any U.S. laws or policies but serves as a statement of U.S. position.